245 related articles for article (PubMed ID: 12015742)
1. Identification of histological features associated with metastatic potential in thin (<1.0 mm) cutaneous melanoma with metastases. A study on behalf of the EORTC Melanoma Group.
Cook MG; Spatz A; Bröcker EB; Ruiter DJ
J Pathol; 2002 Jun; 197(2):188-93. PubMed ID: 12015742
[TBL] [Abstract][Full Text] [Related]
2. Acral lentiginous melanoma: histopathological prognostic features of 121 cases.
Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
Br J Dermatol; 2007 Aug; 157(2):311-8. PubMed ID: 17596173
[TBL] [Abstract][Full Text] [Related]
3. Predictors of regional nodal disease in patients with thin melanomas.
Karakousis GC; Gimotty PA; Botbyl JD; Kesmodel SB; Elder DE; Elenitsas R; Ming ME; Guerry D; Fraker DL; Czerniecki BJ; Spitz FR
Ann Surg Oncol; 2006 Apr; 13(4):533-41. PubMed ID: 16523360
[TBL] [Abstract][Full Text] [Related]
4. The correlation of regression in primary melanoma with sentinel lymph node status.
Kaur C; Thomas RJ; Desai N; Green MA; Lovell D; Powell BW; Cook MG
J Clin Pathol; 2008 Mar; 61(3):297-300. PubMed ID: 17675538
[TBL] [Abstract][Full Text] [Related]
5. Regional nodal metastatic disease is the strongest predictor of survival in patients with thin vertical growth phase melanomas: a case for SLN Staging biopsy in these patients.
Karakousis GC; Gimotty PA; Czerniecki BJ; Elder DE; Elenitsas R; Ming ME; Fraker DL; Guerry D; Spitz FR
Ann Surg Oncol; 2007 May; 14(5):1596-603. PubMed ID: 17285396
[TBL] [Abstract][Full Text] [Related]
6. Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging.
Gimotty PA; Guerry D; Ming ME; Elenitsas R; Xu X; Czerniecki B; Spitz F; Schuchter L; Elder D
J Clin Oncol; 2004 Sep; 22(18):3668-76. PubMed ID: 15302909
[TBL] [Abstract][Full Text] [Related]
7. Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma.
Gimotty PA; Van Belle P; Elder DE; Murry T; Montone KT; Xu X; Hotz S; Raines S; Ming ME; Wahl P; Guerry D
J Clin Oncol; 2005 Nov; 23(31):8048-56. PubMed ID: 16258103
[TBL] [Abstract][Full Text] [Related]
8. High proliferative activity may predict early metastasis of thin melanomas.
Frahm SO; Schubert C; Parwaresch R; Rudolph P
Hum Pathol; 2001 Dec; 32(12):1376-81. PubMed ID: 11774172
[TBL] [Abstract][Full Text] [Related]
9. Re: Cook et al. Identification of histological features associated with metastatic potential in thin (<1.0 mm) cutaneous melanoma with metastases. A study on behalf of the EORTC Melanoma Group. J Pathol 2002; 197: 188-193.
Heenan PJ; Taran JM
J Pathol; 2003 Jan; 199(1):132; author reply 132-3. PubMed ID: 12474238
[No Abstract] [Full Text] [Related]
10. Thin malignant melanomas with regression and metastases.
Ronan SG; Eng AM; Briele HA; Shioura NN; Das Gupta TK
Arch Dermatol; 1987 Oct; 123(10):1326-30. PubMed ID: 3662564
[TBL] [Abstract][Full Text] [Related]
11. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
12. Regression in thin malignant melanoma. Microscopic diagnosis and prognostic importance.
Cooper PH; Wanebo HJ; Hagar RW
Arch Dermatol; 1985 Sep; 121(9):1127-31. PubMed ID: 4037837
[TBL] [Abstract][Full Text] [Related]
13. Thin melanomas.
King R; Googe PB; Mihm MC
Clin Lab Med; 2000 Dec; 20(4):713-29. PubMed ID: 11221511
[TBL] [Abstract][Full Text] [Related]
14. Tumour regression does not increase the risk of sentinel node involvement in thin melanomas.
Cecchi R; Pavesi M; Buralli L; Innocenti S; De Gaudio C
Chir Ital; 2008; 60(2):257-60. PubMed ID: 18689175
[TBL] [Abstract][Full Text] [Related]
15. Amelanotic/hypomelanotic melanoma: clinical and dermoscopic features.
Pizzichetta MA; Talamini R; Stanganelli I; Puddu P; Bono R; Argenziano G; Veronesi A; Trevisan G; Rabinovitz H; Soyer HP
Br J Dermatol; 2004 Jun; 150(6):1117-24. PubMed ID: 15214897
[TBL] [Abstract][Full Text] [Related]
16. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
Nahabedian MY; Tufaro AP; Manson PN
Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
[TBL] [Abstract][Full Text] [Related]
18. Deep "benign" fibrous histiocytoma: clinicopathologic analysis of 69 cases of a rare tumor indicating occasional metastatic potential.
Gleason BC; Fletcher CD
Am J Surg Pathol; 2008 Mar; 32(3):354-62. PubMed ID: 18300816
[TBL] [Abstract][Full Text] [Related]
19. The histopathology of cutaneous malignant melanoma.
Barnhill RL; Mihm MC
Semin Diagn Pathol; 1993 Feb; 10(1):47-75. PubMed ID: 8506417
[TBL] [Abstract][Full Text] [Related]
20. Metastatic patterns in autopsy cases of cutaneous melanoma.
Akslen LA; Heuch I; Hartveit F
Invasion Metastasis; 1988; 8(4):193-204. PubMed ID: 3170114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]